{"id":"NCT00704418","sponsor":"Bausch & Lomb Incorporated","briefTitle":"Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-06","primaryCompletion":"2009-01","completion":"2009-12","firstPosted":"2008-06-24","resultsPosted":"2011-01-26","lastUpdate":"2013-01-18"},"enrollment":156,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Cataract"],"interventions":[{"type":"DRUG","name":"Bromfenac","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Bromfenac","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery","primaryOutcome":{"measure":"Number of Participants With Summed Ocular Inflammation Score (SOIS) of Zero","timeFrame":"Day 15","effectByArm":[{"arm":"Bromfenac","deltaMin":36,"sd":null},{"arm":"Placebo","deltaMin":23,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["21751945"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":73},"commonTop":["Eye Inflammation","Eye Pain","Corneal oedema"]}}